Physician profile
Emma C Stapleton
NPI 1255065785
$1,805.14
in general payments reported to CMS, 2019-2025
23 companies · $999 in 2025
The $999 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $806 · 2025: $999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,805.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $435.55 | 2024-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $331.29 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $206.70 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $169.19 | 2025 | |
| Alnylam Pharmaceuticals INC. | $96.52 | 2024 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $91.89 | 2024-2025 | Camzyos |
| Kestra Medical Technology Services, INC. | $48.19 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $40.04 | 2024 | Farxiga |
| Esperion Therapeutics, INC. | $37.29 | 2025 | Nexletol |
| Lantheus Medical Imaging, INC. | $36.12 | 2024 | |
| Irhythm Technologies, INC. | $36.07 | 2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals International, Plc | $30.68 | 2024 | Arcalyst |
| Pfizer INC. | $29.63 | 2025 | |
| Inspire Medical Systems, INC. | $26.83 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $24.94 | 2025 | Verquvo, Capvaxive |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $23.43 | 2025 | |
| Abiomed | $22.62 | 2024 | Impella |
| Recor Medical INC | $22.11 | 2025 | Paradise Ultrasound Renal Denervation System |
| Janssen Pharmaceuticals, INC | $21.20 | 2024 | Xarelto |
| Amgen INC. | $19.92 | 2024 | Repatha |
| Bridgebio Pharma, INC. | $18.62 | 2025 | Attruby |
| Genzyme Corporation | $18.58 | 2025 | |
| Altathera Pharmaceuticals LLC | $17.73 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Stapleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.